Skip to main content
Log in

Intravascular ultrasound guidance improves patient survival (mortality) after drug-eluting stent implantation: review and updated bibliography

  • Invited Review Article
  • Published:
Cardiovascular Intervention and Therapeutics Aims and scope Submit manuscript

Abstract

Individual studies IVUS vs angiography-guided DES implantation studies, whether randomized clinical trials or registries are underpowered, to show a reduction in mortality, especially at 1 year of follow-up. However, either meta-analyses or the few studies with long-term (> 5 year) follow-up showed that IVUS guidance reduced mortality and improved patient survival, even with second-generation DES.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Jakabcin J, Spacek R, Bystron M, et al. Long-term health outcome and mortality evaluation after invasive coronary treatment using drug eluting stents with or without the IVUS guidance. Randomized control trial. HOME DES IVUS. Catheter Cardiovasc Interv. 2010;75:578–83.

    PubMed  Google Scholar 

  2. Chieffo A, Latib A, Caussin C, et al. A prospective, randomized trial of intravascular-ultrasound guided compared to angiography guided stent implantation in complex coronary lesions: the AVIO trial. Am Heart J. 2013;165:65–72.

    PubMed  Google Scholar 

  3. Kim JS, Kang TS, Mintz GS, et al. Randomized comparison of clinical outcomes between intravascular ultrasound and angiography-guided drug-eluting stent implantation for long coronary artery stenoses. JACC Cardiovasc Interv. 2013;6:369–76.

    PubMed  Google Scholar 

  4. Hong SJ, Kim BK, Shin DH, IVUS-XPL Investigators, et al. Effect of intravascular ultrasound-guided vs angiography-guided everolimus-eluting stent implantation: the IVUS-XPL randomized clinical trial. JAMA. 2015;314:2155–63.

    CAS  PubMed  Google Scholar 

  5. Tian NL, Gami SK, Ye F, et al. Angiographic and clinical comparisons of intravascular ultrasound- versus angiography-guided drug-eluting stent implantation for patients with chronic total occlusion lesions: two-year results from a randomised AIR-CTO study. EuroIntervention. 2015;10:1409–17.

    PubMed  Google Scholar 

  6. Kim BK, Shin DH, Hong MK, CTO-IVUS Study Investigators, et al. Clinical impact of intravascular ultrasound-guided chronic total occlusion intervention with zotarolimus-eluting versus biolimus-eluting stent implantation: randomized study. Circ Cardiovasc Interv. 2015;8:e002592.

    PubMed  Google Scholar 

  7. Tan Q, Wang Q, Liu D, et al. Intravascular ultrasound–guided unprotected left main coronary artery stenting in the elderly. Saudi Med J. 2015;36:549–53.

    PubMed  PubMed Central  Google Scholar 

  8. Zhang JQ, Shi R, Pang W, et al. Application of intravascular ultrasound in stent implantation for small coronary arteries. J Clin Invasive Cardiol. 2016;3:1–8.

    Google Scholar 

  9. Mariani J Jr, Guedes C, Soares P, et al. Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial. JACC Cardiovasc Interv. 2014;7:1287–93.

    PubMed  PubMed Central  Google Scholar 

  10. Zhang J, Gao X, Kan J, et al. Intravascular ultrasound-guided versus angiography-guided implantation of drug-eluting stent in all-comers: the ULTIMATE trial. J Am Coll Cardiol. 2018;72:3126–37.

    PubMed  Google Scholar 

  11. Liu XM, Yang ZM, Liu XK, et al. Intravascular ultrasound-guided drug-eluting stent implantation for patients with unprotected left main coronary artery lesions: a single-center randomized trial. Anatol J Cardiol. 2019;21:83–90.

    CAS  PubMed  Google Scholar 

  12. Agostoni P, Valgimigli M, Van Mieghem CA, et al. Comparison of early outcome of percutaneous coronary intervention for unprotected left main coronary artery disease in the drug-eluting stent era with versus without intravascular ultrasonic guidance. Am J Cardiol. 2005;95:644–7.

    PubMed  Google Scholar 

  13. Roy P, Steinberg DH, Sushinsky SJ, et al. The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. Eur Heart J. 2008;29:1851–7.

    CAS  PubMed  Google Scholar 

  14. Fujimoto H, Tao S, Dohi T, et al. Primary and mid-term outcome of sirolimus-eluting stent implantation with angiographic guidance alone. J Cardiol. 2008;51:18–24.

    PubMed  Google Scholar 

  15. Park SJ, Kim YH, Park DW, Investigators M-C, et al. Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis. Circ Cardiovasc Interv. 2009;2:167–77.

    PubMed  Google Scholar 

  16. Kim SH, Kim YH, Kang SJ, et al. Long-term outcomes of intravascular ultrasound-guided stenting in coronary bifurcation lesions. Am J Cardiol. 2010;106:612–8.

    PubMed  Google Scholar 

  17. Maluenda G, Lemesle G, Ben-Dor I, et al. Impact of intravascular ultrasound guidance in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv. 2010;75:86–92.

    PubMed  Google Scholar 

  18. Claessen BE, Mehran R, Mintz GS, et al. Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents. JACC Cardiovasc Interv. 2011;4:974–81.

    PubMed  Google Scholar 

  19. Kim JS, Hong MK, Ko YG, et al. Impact of intravascular ultrasound guidance on long-term clinical outcomes in patients treated with drug-eluting stent for bifurcation lesions: data from a Korean multicenter bifurcation registry. Am Heart J. 2011;161:180–7.

    CAS  PubMed  Google Scholar 

  20. Youn YJ, Yoon J, Lee JW, et al. Intravascular ultrasound-guided primary percutaneous coronary intervention with drug-eluting stent implantation in patients with ST-segment elevation myocardial infarction. Clin Cardiol. 2011;34:706–13.

    PubMed  PubMed Central  Google Scholar 

  21. Chen SL, Ye F, Zhang JJ, et al. Intravascular ultrasound-guided systematic two-stent techniques for coronary bifurcation lesions and reduced late stent thrombosis. Catheter Cardiovasc Interv. 2013;81:456–63.

    PubMed  Google Scholar 

  22. Hur SH, Kang SJ, Kim YH, et al. Impact of intravascular ultrasound-guided percutaneous coronary intervention on long-term clinical outcomes in a real world population. Catheter Cardiovasc Interv. 2013;81:407–16.

    PubMed  Google Scholar 

  23. Park KW, Kang SH, Yang HM, et al. Impact of intravascular ultrasound guidance in routine percutaneous coronary intervention for conventional lesions: data from the EXCELLENT trial. Int J Cardiol. 2013;167:721–6.

    PubMed  Google Scholar 

  24. Witzenbichler B, Maehara A, Weisz G, et al. Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the ADAPT-DES Study. Circulation. 2014;129:463–70.

    CAS  PubMed  Google Scholar 

  25. Ahn SG, Yoon J, Sung JK, et al. Intravascular ultrasound-guided percutaneous coronary intervention improves the clinical outcome in patients undergoing multiple overlapping drug-eluting stents implantation. Korean Circ J. 2013;43:231–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Ahn JM, Han S, Park YK, RESET Investigators, et al. Differential prognostic effect of intravascular ultrasound use according to implanted stent length. Am J Cardiol. 2013;111:829–35.

    PubMed  Google Scholar 

  27. Yoon YW, Shin S, Kim BK, Investigators R, et al. Usefulness of intravascular ultrasound to predict outcomes in short-length lesions treated with drug-eluting stents. Am J Cardiol. 2013;112:642–6.

    CAS  PubMed  Google Scholar 

  28. de la Torre Hernandez JM, Baz Alonso JA, Gómez Hospital JA, IVUS-TRONCO-ICP Spanish study, et al. Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: pooled analysis at the patient-level of 4 registries. JACC Cardiovasc Interv. 2014;7:244–54.

    PubMed  Google Scholar 

  29. Hong SJ, Kim BK, Shin DH, K-CTO Registry, et al. Usefulness of intravascular ultrasound guidance in percutaneous coronary intervention with second-generation drug-eluting stents for chronic total occlusions (from the Multicenter Korean-Chronic Total Occlusion Registry). Am J Cardiol. 2014;114:534–40.

    PubMed  Google Scholar 

  30. Gao XF, Kan J, Zhang YJ, et al. Comparison of one-year clinical outcomes between intravascular ultrasound-guided versus angiography-guided implantation of drug-eluting stents for left main lesions: a single-center analysis of a 1,016-patient cohort. Patient Prefer Adher. 2014;8:1299–309.

    Google Scholar 

  31. Fröhlich GM, Redwood S, Rakhit R, et al. Long-term survival in patients undergoing percutaneous interventions with or without intracoronary pressure wire guidance or intracoronary ultrasonographic imaging: a large cohort study. JAMA Intern Med. 2014;174:1360–6.

    PubMed  Google Scholar 

  32. Yazici HU, Agamaliyev M, Aydar Y, Goktekin O. The impact of intravascular ultrasound guidance during drug eluting stent implantation on angiographic outcomes. Eur Rev Med Pharmacol Sci. 2015;19:3012–7.

    CAS  PubMed  Google Scholar 

  33. Singh V, Badheka AO, Arora S, et al. Comparison of in-hospital mortality, length of hospitalization, costs, and vascular complications of percutaneous coronary interventions guided by ultrasound versus angiography. Am J Cardiol. 2015;115:1357–66.

    PubMed  Google Scholar 

  34. Magalhaes MA, Minha S, Torguson R, et al. The effect of complete percutaneous revascularisation with and without intravascular ultrasound guidance in the drug-eluting stent era. EuroIntervention. 2015;11:625–33.

    PubMed  Google Scholar 

  35. Nakatsuma K, Shiomi H, Morimoto T, CREDO-Kyoto AMI investigators, et al. Intravascular ultrasound guidance vs angiographic guidance in primary percutaneous coronary intervention for ST segment elevation myocardial infarction—long-term clinical outcomes from the CREDO-Kyoto AMI Registry. Circ J. 2016;80:477–84.

    PubMed  Google Scholar 

  36. Patel Y, Depta JP, Patel JS, et al. Impact of intravascular ultrasound on the long-term clinical outcomes in the treatment of coronary ostial lesions. Catheter Cardiovasc Interv. 2016;87:232–40.

    PubMed  Google Scholar 

  37. Ahmed K, Jeong MH, Chakraborty R, et al. Role of intravascular ultrasound in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Am J Cardiol. 2011;108:8–14.

    PubMed  Google Scholar 

  38. Roy P, Torguson R, Okabe T, et al. Angiographic and procedural correlates of stent thrombosis after intracoronary implantation of drug-eluting stents. J Interv Cardiol. 2007;20:307–13.

    PubMed  Google Scholar 

  39. Gerber RT, Latib A, Ielasi A, et al. Defining a new standard for IVUS optimized drug eluting stent implantation: the PRAVIO study. Catheter Cardiovasc Interv. 2009;74:348–56.

    CAS  PubMed  Google Scholar 

  40. Biondi-Zoccai G, Sheiban I, Romagnoli E, et al. Is intravascular ultrasound beneficial for percutaneous coronary intervention of bifurcation lesions? Evidence from a 4314-patient registry. Clin Res Cardiol. 2011;100:1021–8.

    PubMed  Google Scholar 

  41. Wakabayashi K, Lindsay J, Laynez-Carnicero A, et al. Utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention for type C lesions. J Interv Cardiol. 2012;25:452–9.

    PubMed  Google Scholar 

  42. Patel Y, Depta JP, Novak E, et al. Long-term outcomes with use of intravascular ultrasound for the treatment of coronary bifurcation lesions. Am J Cardiol. 2012;109:960–5.

    PubMed  Google Scholar 

  43. De la Torre Hernandez JM, Alfonso F, Sanchez Recalde A, ESTROFA-LM Study Group, et al. Comparison of paclitaxel-eluting stents (Taxus) and everolimus-eluting stents (Xience) in left main coronary artery disease with 3 years follow-up (from the ESTROFA-LM registry). Am J Cardiol. 2013;111:676–83.

    PubMed  Google Scholar 

  44. Andell P, Karlsson S, Mohammad MA, et al. Intravascular ultrasound guidance is associated with better outcome in patients undergoing unprotected left main coronary artery stenting compared with angiography guidance alone. Circ Cardiovasc Interv. 2017;10:e004813.

    PubMed  Google Scholar 

  45. Tian J, Guan C, Wang W, et al. Intravascular ultrasound guidance improves the long-term prognosis in patients with unprotected left main coronary artery disease undergoing percutaneous coronary intervention. Sci Rep. 2017;7:2377.

    PubMed  PubMed Central  Google Scholar 

  46. Chen L, Xu T, Xue XJ, Zhang JJ, Ye F, Tian NL, Chen SL. Intravascular ultrasound-guided drug-eluting stent implantation is associated with improved clinical outcomes in patients with unstable angina and complex coronary artery true bifurcation lesions. Int J Cardiovasc Imaging. 2018. https://doi.org/10.1007/s10554-018-1393-2.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Maehara A, Mintz GS, Witzenbichler B, et al. Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents. Circ Cardiovasc Interv. 2018;11(11):e006243. https://doi.org/10.1161/CIRCINTERVENTIONS.117.006243.

    Article  PubMed  Google Scholar 

  48. Amat-Santos IJ, Martin-Yuste V, Fernández-Díaz JA, et al. Procedural, functional and prognostic outcomes following recanalization of coronary chronic total occlusions. Results of the Iberian Registry. Rev Esp Cardiol (Engl Ed). 2018. https://doi.org/10.1016/j.rec.2018.05.020.

    Article  PubMed  Google Scholar 

  49. Choi KH, Song YB, Lee JM, et al. Impact of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention on Long-Term Clinical Outcomes in Patients Undergoing Complex Procedures. JACC Cardiovasc Interv. 2019;12:607–20.

    PubMed  Google Scholar 

  50. Zhang J, Gao X, Ge Z, et al. Impact of intravascular ultrasound-guided drug-eluting stent implantation in patients with chronic kidney disease: results from ULTIMATE trial. Catheter Cardiovasc Interv. 2019. https://doi.org/10.1002/ccd.28308.

    Article  PubMed  Google Scholar 

  51. Kuno T, Numasawa Y, Sawano M, et al. Real-world use of intravascular ultrasound in Japan: a report from contemporary multicenter PCI registry. Heart Vessels. 2019. https://doi.org/10.1007/s00380-019-01427-9.

    Article  PubMed  Google Scholar 

  52. Zhang Y, Farooq V, Garcia-Garcia HM, et al. Comparison of intravascular ultrasound versus angiography-guided drug-eluting stent implantation: a meta-analysis of one randomised trial and ten observational studies involving 19,619 patients. EuroIntervention. 2012;8:855–65.

    PubMed  Google Scholar 

  53. Klersy C, Ferlini M, Raisaro A, et al. Use of IVUS guided coronary stenting with drug eluting stent: a systematic review and meta-analysis of randomized controlled clinical trials and high quality observational studies. Int J Cardiol. 2013;170:54–63.

    PubMed  Google Scholar 

  54. Jang JS, Song YJ, Kang W, et al. Intravascular ultrasound-guided implantation of drug-eluting stents to improve outcome: a meta-analysis. JACC Cardiovasc Interv. 2014;7:233–43.

    PubMed  Google Scholar 

  55. Ahn JM, Kang SJ, Yoon SH, et al. Meta-analysis of outcomes after intravascular ultrasound-guided versus angiography-guided drug-eluting stent implantation in 26,503 patients enrolled in three randomized trials and 14 observational studies. Am J Cardiol. 2014;113:1338–47.

    PubMed  Google Scholar 

  56. Zhang YJ, Pang S, Chen XY, et al. Comparison of intravascular ultrasound guided versus angiography guided drug eluting stent implantation: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2015;15:153.

    PubMed  PubMed Central  Google Scholar 

  57. Alsidawi S, Effat M, Rahman S, Abdallah M, Leesar M. The role of vascular imaging in guiding routine percutaneous coronary interventions: a meta-analysis of bare Metal stent and drug-eluting stent trials. Cardiovasc Ther. 2015;33:360–6.

    PubMed  Google Scholar 

  58. Nerlekar N, Cheshire CJ, Verma KP, et al. Intravascular ultrasound guidance improves clinical outcomes during implantation of both first and second-generation drug-eluting stents: a meta-analysis. EuroIntervention. 2017;12:1632–42.

    PubMed  Google Scholar 

  59. Steinvil A, Zhang YJ, Lee SY, et al. Intravascular ultrasound-guided drug-eluting stent implantation: an updated meta-analysis of randomized control trials and observational studies. Int J Cardiol. 2016;216:133–9.

    PubMed  Google Scholar 

  60. Elgendy IY, Mahmoud AN, Elgendy AY, et al. Outcomes with intravascular ultrasound-guided stent implantation: a meta-analysis of randomized trials in the era of drug-eluting stents. Circ Cardiovasc Interv. 2016;9:e003700.

    CAS  PubMed  Google Scholar 

  61. Shin DH, Hong SJ, Mintz GS, et al. Effects of intravascular ultrasound-guided versus angiography-guided new-generation drug-eluting stent implantation: meta-Analysis With Individual Patient-Level Data From 2,345 Randomized Patients. JACC Cardiovasc Interv. 2016;9:2232–9.

    PubMed  Google Scholar 

  62. Bavishi C, Sardar P, Chatterjee S, et al. Intravascular ultrasound–guided vs angiography-guided drug-eluting stent implantation in complex coronary lesions: meta-analysis of randomized trials. Am Heart J. 2017;185:26–34.

    PubMed  Google Scholar 

  63. Fan ZG, Gao XF, Li XB, et al. The outcomes of intravascular ultrasound-guided drug-eluting stent implantation among patients with complex coronary lesions: a comprehensive meta-analysis of 15 clinical trials and 8,084 patients. Anatol J Cardiol. 2017;17:258–68.

    PubMed  PubMed Central  Google Scholar 

  64. Ye Y, Yang M, Zhang S, Zeng Y. Percutaneous coronary intervention in left main coronary artery disease with or without intravascular ultrasound: a meta-analysis. PLoS One. 2017;12(6):e0179756.

    PubMed  PubMed Central  Google Scholar 

  65. Raber L, Mintz GS, Koskinas KC, et al. Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. Eur Heart J. 2018;39:3281–300.

    PubMed  Google Scholar 

  66. Wang Y, Mintz GS, Gu Z, Qi Y, Wang Y, Liu M, Wu X. Meta-analysis and systematic review of intravascular ultrasound versus angiography-guided drug eluting stent implantation in left main coronary disease in 4592 patients. BMC Cardiovasc Disord. 2018;18:115. https://doi.org/10.1186/s12872-018-0843-z.

    Article  PubMed  PubMed Central  Google Scholar 

  67. DiMario C, Koskinas KC, Raber L. Clinical benefit of IVUS guidance for coronary stenting. J Am Coll Cardiol. 2018;72:3128–41.

    Google Scholar 

  68. Gao XF, Wang ZM, Wang F, et al. Intravascular ultrasound guidance reduces cardiac death and coronary revascularization in patients undergoing drug-eluting stent implantation: results from a meta-analysis of 9 randomized trials and 4724 patients. Int J Cardiovasc Imaging. 2019. https://doi.org/10.1007/s10554-019-01555-3.

    Article  PubMed  Google Scholar 

  69. Elgendy IY, Mahmoud AN, Elgendy AY, Mintz GS. Intravascular ultrasound-guidance is associated with lower cardiovascular mortality and myocardial infarction for drug-eluting stent implantation1insights from an updated meta-analysis of randomized trials. Circ J. 2019;83:1410–3.

    PubMed  Google Scholar 

  70. de la Torre-Hernández JM, Alfonso F, Hernández F, et al. Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos). J Am Coll Cardiol. 2008;51:986–90.

    PubMed  Google Scholar 

  71. Kimura T, Morimoto T, Kozuma K, et al. Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: observations from the Registry of Stent Thrombosis for Review and Reevaluation (RESTART). Circulation. 2010;122:52–61.

    PubMed  Google Scholar 

  72. Thayssen P, Jensen LO, Lassen JF, Western Denmark Heart Registry, et al. The risk and prognostic impact of definite stent thrombosis or in-stent restenosis after coronary stent implantation. EuroIntervention. 2012;8:591–8.

    PubMed  Google Scholar 

  73. Secemsky EA, Matteau A, Yeh RW, PROTECT Trial Investigators, et al. Comparison of short- and long-term cardiac mortality in early versus late stent thrombosis (from Pooled PROTECT Trials). Am J Cardiol. 2015;115:1678–84.

    PubMed  Google Scholar 

  74. Armstrong EJ, Feldman DN, Wang TY, et al. Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis. JACC Cardiovasc Interv. 2012;5:131–40.

    PubMed  Google Scholar 

  75. Armstrong EJ, Maddox TM, Carey EP, Grunwald GK, Shunk KA. Mortality after presentation with stent thrombosis is associated with time from index percutaneous coronary intervention: a report from the VA CART program. Am Heart J. 2014;168:560–7.

    PubMed  Google Scholar 

  76. Dohi T, Maehara A, Witzenbichler B, et al. Etiology, frequency, and clinical outcomes of myocardial infarction after successful drug-eluting stent implantation: two-year follow-up from the ADAPT-DES study. Circ Cardiovasc Interv. 2015;8:e002447. https://doi.org/10.1161/CIRCINTERVENTIONS.114.002447.

    Article  CAS  PubMed  Google Scholar 

  77. Goel SS, Dilip Gajulapalli R, Athappan G, et al. Management of drug eluting stent in-stent restenosis: a systematic review and meta-analysis. Catheter Cardiovasc Interv. 2016;87:1080–91.

    PubMed  Google Scholar 

  78. Lee JM, Rhee TM, Hahn JY, et al. Comparison of outcomes after treatment of in-stent restenosis using newer generation drug-eluting stents versus drug-eluting balloon: patient-level pooled analysis of Korean Multicenter in-Stent Restenosis Registry. Int J Cardiol. 2017;230:181–90.

    PubMed  Google Scholar 

  79. Basavarajaiah S, Naganuma T, Latib A, et al. Treatment of drug-eluting stent restenosis: comparison between drug-eluting balloon versus second-generation drug-eluting stents from a retrospective observational study. Catheter Cardiovasc Interv. 2016;88:522–8.

    PubMed  Google Scholar 

  80. Alfonso F, Pérez-Vizcayno MJ, García Del Blanco B, et al. Everolimus-eluting stents in patients with bare-metal and drug-eluting in-stent restenosis: results from a patient-level pooled analysis of the RIBS IV and V trials. Circ Cardiovasc Interv. 2016. https://doi.org/10.1161/circinterventions.115.003479.

    Article  PubMed  Google Scholar 

  81. Redfors B, Généreux P, Witzenbichler B, et al. Percutaneous coronary intervention of lesions with in-stent restenosis: a report from the ADAPT-DES study. Am Heart J. 2018;197:142–9.

    PubMed  Google Scholar 

Download references

Acknowledgements

Dr. Mintz receives honoraria from BostonScientific and Philips.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gary S. Mintz.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mintz, G.S. Intravascular ultrasound guidance improves patient survival (mortality) after drug-eluting stent implantation: review and updated bibliography. Cardiovasc Interv and Ther 35, 37–43 (2020). https://doi.org/10.1007/s12928-019-00616-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12928-019-00616-7

Keywords

Navigation